Tianjin Ringpu Bio-Technology Co.,Ltd.’s Net Profit Dropped 19.9% in First Three Quarters of 2022
Listen to the full version

Tianjin Ringpu Bio-Technology Co.,Ltd. (天津瑞普生物技术股份有限公司) (300119.SZ) reported a net profit of 256 million yuan in the first three quarters of 2022, down 19.9% year-on-year.
Meanwhile, the company posted 1.5 billion yuan in revenue, down 1.5% year-on-year.
At the end of the reporting period, it had 6.2 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 29%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR